Impact of Burkholderia Infection on Lung Transplantation in Cystic Fibrosis
- 15 August 2008
- journal article
- research article
- Published by American Thoracic Society in American Journal of Respiratory and Critical Care Medicine
- Vol. 178 (4), 363-371
- https://doi.org/10.1164/rccm.200712-1834oc
Abstract
Lung transplantation offers the only survival option for patients with cystic fibrosis (CF) with end-stage pulmonary disease. Infection with Burkholderia species is typically considered a contraindication to transplantation in CF. However, the risks posed by different Burkholderia species on transplantation outcomes are poorly defined. To quantify the risks of infection with Burkholderia species on survival before and after lung transplantation in patients with CF. Multivariate Cox survival models assessed hazard ratios of infection with Burkholderia species in 1,026 lung transplant candidates and 528 lung transplant recipients. Lung allocation scores, incorporating Burkholderia infection status, were calculated for transplant candidates. Transplant candidates infected with different Burkholderia species did not have statistically different mortality rates. Among transplant recipients infected with B. cenocepacia, only those infected with nonepidemic strains had significantly greater post-transplant mortality compared with uninfected patients (hazard ratio [HR], 2.52; 95% confidence interval [CI], 1.04-6.12; P = 0.04). Hazards were similar between uninfected transplant recipients and those infected with B. multivorans (HR, 0.66; 95% CI, 0.27-1.56; P = 0.34). Transplant recipients infected with B. gladioli had significantly greater post-transplant mortality than uninfected patients (HR, 2.23; 95% CI, 1.05-4.74; P = 0.04). Once hazards for species/strain were included, lung allocation scores of B. multivorans-infected transplant candidates were comparable to uninfected candidate scores, whereas those of candidates infected with nonepidemic B. cenocepacia or B. gladioli were lower. Post-transplant mortality among patients with CF infected with Burkholderia varies by infecting species. This variability should be taken into account in evaluating lung transplantation candidates.This publication has 35 references indexed in Scilit:
- Development of the New Lung Allocation System in the United StatesAmerican Journal of Transplantation, 2006
- Use of Lung Transplantation Survival Models to Refine Patient Selection in Cystic FibrosisAmerican Journal of Respiratory and Critical Care Medicine, 2005
- Survival Effect of Lung Transplantation Among Patients With Cystic FibrosisJAMA, 2001
- Infection with Burkholderia cepacia in Cystic FibrosisAmerican Journal of Respiratory and Critical Care Medicine, 2001
- Effect of diagnosis on survival benefit of lung transplantation for end-stage lung diseaseThe Lancet, 1998
- Subdural Empyema Due to Burkholderia Cepacia: An Unusual Complication after Lung Transplantation for Cystic FibrosisJournal of the Royal Society of Medicine, 1997
- The effects of panresistant bacteria in cystic fibrosis patients on lung transplant outcome.American Journal of Respiratory and Critical Care Medicine, 1997
- Bronchiolitis Obliterans Organizing Pneumonia (BOOP) in Lung Transplant RecipientsSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 1996
- A Decade of Lung TransplantationAnnals of Surgery, 1993
- Double-lung transplantation in mechanically ventilated patients with cystic fibrosisThe Annals of Thoracic Surgery, 1993